Scatec ASA
Scatec ASA - Buy-back of bonds and exercise of call option
Scatec ASA - Buy-back of bonds and exercise of call option
Oslo, 6 February 2025: Reference is made to the stock exchange notice 5 February 2025 regarding Scatec ASA's issuance of new green bonds.
In conjunction with the bond issue, Scatec has bought back EUR 9.1 million of outstanding bonds with ticker “SCATC03 ESG” (ISIN NO0010931181), which will be cancelled subsequently. Scatec will call the remaining SCATC03 bonds on 20 February 2025. Please see the attached notice from Nordic Trustee AS for further information about the call option.
DNB Markets, Nordea and SpareBank 1 Markets acted as Joint Lead Managers for the transaction.
For further information, please contact: Andreas Austrell, VP IR, tel: +47 974 38 686
About Scatec ASA:
Scatec is a leading renewable energy solutions provider, accelerating access to reliable and affordable clean energy emerging markets. As a long-term player, we develop, build, own, and operate renewable energy plants, with 5 GW in operation and under construction across five continents today. We are committed to grow our renewable energy capacity, delivered by our passionate employees and partners who are driven by a common vision of 'Improving our Future'. Scatec is headquartered in Oslo, Norway and listed on the Oslo Stock Exchange under the ticker symbol 'SCATC'. To learn more, visit www.scatec.com or connect with us on LinkedIn
This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Biogen Inc.14.10.2025 01:30:00 CEST | Press release
LEQEMBI® IQLIK™(lecanemab-irmb) Subcutaneous Autoinjector Named to TIME’s “Best Inventions of 2025”
Bombardier Inc.13.10.2025 22:02:56 CEST | Press release
Bombardier Global 8000, The World’s Fastest Business Jet, Gets Even Faster with a New Top Speed of Mach 0.95
Zymeworks Inc.13.10.2025 22:00:00 CEST | Press release
Zymeworks to Present Clinical Data from the Phase 1 trial of ZW191, an Antibody-Drug Conjugate Targeting Folate Receptor-⍺, at AACR-NCI-EORTC International Conference
Bombardier Inc.13.10.2025 21:00:00 CEST | Press release
Bombardier Unveils Comlux as Global 8000 Aircraft Customer, Delivery Confirmed for 2026
Cosmos Health Inc.13.10.2025 20:05:46 CEST | Press release
Cosmos Health Purchases an Additional $300,000 in Ethereum Under Its $300 Million Digital Assets Facility; Total Investment Reaches $1.8 Million
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom